![Andrew Furness Profile](https://pbs.twimg.com/profile_images/1711361364327837696/OUOREWnI_x96.jpg)
Andrew Furness
@ajsfurness
Followers
642
Following
2K
Statuses
1K
Consultant Medical Oncologist, Solid Tumour Cell Therapy Lead @royalmarsdenNHS & Team Leader @ICR_London; views my own
London, U.K.
Joined August 2013
RT @BeckiLee: First day of Lee Lab (further name tbc) !!! Exciting and a bit scary! Any tips and advice very gratefully received!! šš httpsā¦
0
5
0
RT @OncoDailyIO: Toxicity management strategies for solid tumour cell therapy - @JulveMax
@esmo_iotech @sophiawoā¦
0
4
0
RT @sophiawongyn: Been sharing this review on solid tumour cellular therapy toxicity management since #ESMO24 and am delighted to share fulā¦
0
4
0
RT @JulveMax: Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in @esmo_iotech . Aā¦
0
2
0
RT @TheCrick: We're delighted to lead a new project with @RoyalMarsdenNHS to study responses to cancer immunotherapy. The platform has reā¦
0
24
0
RT @AdamSharpMedOnc: Congratulations Dr Juliet Carmichael from the de Bono team @ICR_London @royalmarsdenNHS providing an overview of theraā¦
0
4
0
RT @sandrapdangelo: Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the fā¦
0
28
0
RT @HTawbi_MD: Our own Prof. Roda Amaria ā¦@MDAndersonNewsā© presenting first results of engineered T cell therapy OBX-115, eliminates need fā¦
0
9
0
RT @MSKCancerCenter: Join sarcoma oncologist Dr. Sandra DāAngelo (@sandrapdangelo) as she shares analysis of the pivotal IGNYTE-ESO trial oā¦
0
5
0
RT @DrSapnaPatel: So happy to be present to see this historic moment @ASCO #ASCO24 #melanoma #melsm š š
Congratulations @ProfCUBlankNKI aā¦
0
9
0
RT @marklewismd: .ā¦@SunitaPuriMDā© suggests that, if we are to heal ourselves as oncologists, we need to separate the endpoint of cure fromā¦
0
30
0
RT @DrBetofMDPhD: Next up IOV-COM-202 with front line data for #TIL + pembro in front line melanoma treatment. This is the lead up to the oā¦
0
19
0
RT @Annals_Oncology: IOV-COM-202 cohort 1A - Efficacy of lifileucel, an autologous TIL cell therapy & pembro in pts w/ ICI-naive unresectabā¦
0
1
0
RT @JulveMax: En route to #ASCO24 for the first time! Come and check out our poster on Saturday at board #355 1:30pm Hall A https://t.co/ā¦
0
4
0
RT @uclnews: Congratulations to Professors Christopher Denton @IIT_UCL, Alison Rodger @UCLGlobalHealth, @Mayor_lab @UCLBiosciences & @SQuezā¦
0
17
0
Excellent short commentary led by @JulveMax and @DrMarkLythgoe. First-line trials now in progress! @royalmarsdenNHS @RMresearch_ @royalmarsden @IovanceBio
Pleased to share our @trendscancer article on the @US_FDA approval of lifileucel for melanoma. š§¬First cellular therapy approved for solid tumours š§¬Could in-house manufacture slash future TIL costs? @DrMarkLythgoe @ajsfurness @royalmarsdenNHS
0
0
6